Please assess the completion status of the following clinical trial:

Trial Title: Triggering of Follicular Maturation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Infertile couples wishing to do intracytoplasmic injection trial .~2. first intracytoplasmic injection trial~3. Body mass index:18-30.~5-Antral follicular count: more than 5 follicles in one ovary 6-normal, mild or moderate male factor infertility. 7- Antimullerian hormone \>1 ng/ml~Exclusion Criteria:~1. Azoospermic male.~2. Body mass index more than 29.~3. Patients with endometriosis .~4. Antimullerian hormone \< 1 ng/ml

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Human chorionic gonadotrophin group (Type: EXPERIMENTAL): Patients will receive Human chorionic gonadotrohpin injection 5000 unit
- Human chorionic gonadotrophin + agonist group (Type: ACTIVE_COMPARATOR): patients will receive both Human chorionic gonadotrophin (2500 unit) and gonadotrophin releasing hormone agonist 1mg leuprolide acetate

Based on this trial design, predict the completion outcome and termination type (if applicable).